Lexeo TherapeuticsLXEO
那斯達克 · USD
9.80
+0.07
(+0.72%)
收盤 12/12 04:58 (UTC+8)
12/12 04:58 (UTC+8)
Lexeo TherapeuticsLXEO
9.80
+0.07
(+0.72%)
財務數據
損益表
- 0.00
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | 0 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | 0 |
營業費用 | 21,648 | 30,688 | 33,805 | 27,382 | 31,543 | 23,550 | 23,291 | 14,974 | 20,273 | 13,975 |
研發費用 | 15,695 | 14,721 | 17,171 | 18,366 | 23,423 | 16,560 | 15,742 | 8,210 | 17,246 | 11,236 |
推銷及管理費用 | 5,953 | 15,967 | 16,634 | 9,016 | 8,120 | 6,990 | 7,549 | 6,764 | 3,027 | 2,739 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -21,648 | -30,688 | -33,805 | -27,382 | -31,543 | -23,550 | -23,291 | -14,974 | -20,273 | -13,975 |
其他收入及費用 | 1,387 | 4,610 | 1,177 | 1,488 | 2,089 | 2,347 | 1,646 | 837 | 217 | - |
利息費用 | 22 | 25 | 28 | 30 | 35 | 35 | 37 | 50 | 52 | 53 |
稅前純益 | -20,283 | -26,103 | -32,656 | -25,924 | -29,489 | -21,238 | -21,682 | -14,187 | -20,108 | -13,441 |
所得稅 | - | - | - | - | - | - | - | - | - | 0 |
稅後純益 | -20,283 | -26,103 | -32,656 | -25,924 | -29,489 | -21,238 | -21,682 | -14,187 | -20,108 | -13,441 |
基本每股稅後盈餘(元) | -0.33 | -0.60 | -0.99 | -0.79 | -0.89 | -0.64 | -0.77 | - | -0.08 | -0.05 |
稀釋每股稅後盈餘(元) | -0.33 | -0.60 | -0.99 | -0.78 | -0.90 | -0.64 | -0.77 | 19.84 | -1.24 | -0.05 |
基本平均股數(千股) | 60980.00 | 43573.00 | 33113.00 | 33106.00 | 33063.00 | 33001.00 | 27979.00 | - | 251693.00 | 251693.00 |
稀釋平均股數(千股) | 60980.00 | 43573.00 | 33113.00 | 33106.00 | 33063.00 | 33001.00 | 27979.00 | - | 251693.00 | 251693.00 |
還原基本每股稅後盈餘(元) | -0.33 | -0.60 | -0.99 | -0.79 | -0.89 | -0.64 | -0.77 | - | -0.80 | -0.53 |
還原稀釋每股稅後盈餘(元) | -0.33 | -0.60 | -0.99 | -0.78 | -0.90 | -0.64 | -0.77 | 19.84 | -12.37 | -0.53 |
還原基本平均股數(千股) | 60,980 | 43,573 | 33,113 | 33,106 | 33,063 | 33,001 | 27,979 | - | 25,169 | 25,169 |
還原稀釋平均股數(千股) | 60,980 | 43,573 | 33,113 | 33,106 | 33,063 | 33,001 | 27,979 | - | 25,169 | 25,169 |
EBITDA(千元) | -20,128 | -25,982 | -32,556 | -25,842 | -29,371 | -21,126 | -21,576 | -14,060 | -18,819 | -12,942 |